Burkitt's lymphoma
View article: Clinical and molecular variations in Burkitt lymphoma
Clinical and molecular variations in Burkitt lymphoma Open
View article: Supplementary Appendix 1 from Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies
Supplementary Appendix 1 from Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies Open
Supplementary Figure and Table legends
View article: Table S1 from Distinct Genetically Determined Origins of <i>Myd88</i>/<i>BCL2</i>-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies
Table S1 from Distinct Genetically Determined Origins of <i>Myd88</i>/<i>BCL2</i>-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies Open
Table S1 contains the p values of comparisons of the V gene usage in non-malignant GC B cells between the individual genotypes. These comparisons were done on the family, gene and allele level. V usage was compared for all BCR sequences as…
View article: Table S2 from Distinct Genetically Determined Origins of <i>Myd88</i>/<i>BCL2</i>-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies
Table S2 from Distinct Genetically Determined Origins of <i>Myd88</i>/<i>BCL2</i>-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies Open
Table S2 contains a summary of the B cell receptor sequencing data of lymphoma samples. It includes 1) an overview of the investigated samples, 2) a list of characteristics of the dominant clone of each lymphoma sample, 3) a list comparing…
View article: Burkitt Lymphoma Presenting as Renal Failure: Learning from Diagnostic Pitfalls in Pediatrics
Burkitt Lymphoma Presenting as Renal Failure: Learning from Diagnostic Pitfalls in Pediatrics Open
View article: Sir Michael Anthony Epstein. 18 May 1921 — 6 February 2024
Sir Michael Anthony Epstein. 18 May 1921 — 6 February 2024 Open
Sir Michael Anthony (Tony) Epstein will forever be known for his discovery of the eponymous Epstein–Barr virus (EBV), the first human tumour virus and the foundation stone of a new science, human tumour virology. After medical training, Ep…
View article: PREreview of "The Impact of Malaria-Induced Neutrophil Subset Shift and a Link to Burkitt Lymphoma"
PREreview of "The Impact of Malaria-Induced Neutrophil Subset Shift and a Link to Burkitt Lymphoma" Open
This Zenodo record is a permanently preserved version of a PREreview. You can view the complete PREreview at https://prereview.org/reviews/17637012. Does the introduction explain the objective of the research presented in the preprint? Yes…
View article: PREreview of "The Impact of Malaria-Induced Neutrophil Subset Shift and a Link to Burkitt Lymphoma"
PREreview of "The Impact of Malaria-Induced Neutrophil Subset Shift and a Link to Burkitt Lymphoma" Open
This Zenodo record is a permanently preserved version of a PREreview. You can view the complete PREreview at https://prereview.org/reviews/17637012. Does the introduction explain the objective of the research presented …
View article: Polatuzumab vedotin plus rituximab with chemotherapy in newly diagnosed pediatric stage IV Burkitt lymphoma: case report highlighting early complete remission
Polatuzumab vedotin plus rituximab with chemotherapy in newly diagnosed pediatric stage IV Burkitt lymphoma: case report highlighting early complete remission Open
Although pediatric Burkitt lymphoma is considered curable, some patients still have a poor prognosis. Lack of early or complete response is an adverse prognostic factor. Therefore, improving patients’ sensitivity to initial treatment and a…
View article: High Mortality Rate Among Children and Adolescents with Cancer Treated in Burkina Faso
High Mortality Rate Among Children and Adolescents with Cancer Treated in Burkina Faso Open
Data on childhood cancer mortality are scarce in Burkina Faso. We estimated pediatric cancer mortality and identified its associated factors at the Yalgado Ouédraogo University Hospital Center (CHUYO) in Ouagadougou (Burkina Faso). We cond…
View article: What is the role of stem cell transplant in the treatment of Burkitt lymphoma?
What is the role of stem cell transplant in the treatment of Burkitt lymphoma? Open
While primarily reserved for relapsed or high-risk cases, stem cell transplantation, particularly autologous transplantation, has a significant role in the treatment of Burkitt lymphoma, offering a potential route to long-term remission.
View article: What is the role of stem cell transplant in the treatment of Burkitt lymphoma?
What is the role of stem cell transplant in the treatment of Burkitt lymphoma? Open
While primarily reserved for relapsed or high-risk cases, stem cell transplantation, particularly autologous transplantation, has a significant role in the treatment of Burkitt lymphoma, offering a potential route to long-term remission.
View article: A narrative review on the lactic acidosis and hypoglycemia in burkitt lymphoma: navigating metabolic changes
A narrative review on the lactic acidosis and hypoglycemia in burkitt lymphoma: navigating metabolic changes Open
Background: Burkitt lymphoma is a highly aggressive B-cell non-Hodgkin lymphoma closely associated with Epstein-Barr virus (EBV) infection and driven by MYC oncogene overexpression. It presents in three clinical forms: endemic, sporadic, a…
View article: Navigating Rare Presentations: Recurrent Burkitt Lymphoma Presenting as a Jejunal Mass
Navigating Rare Presentations: Recurrent Burkitt Lymphoma Presenting as a Jejunal Mass Open
Burkitt lymphoma (BL) is an aggressive B‐cell malignancy characterized by rapid progression and MYC gene translocations. Jejunal involvement in BL is rare compared to more common sites like the lymph nodes and central nervous system. Diagn…
View article: Grade 4 Mucositis Secondary to Methotrexate Use in a Pediatric Patient With Stage IV Burkitt Lymphoma: A Case Report
Grade 4 Mucositis Secondary to Methotrexate Use in a Pediatric Patient With Stage IV Burkitt Lymphoma: A Case Report Open
Non-Hodgkin lymphoma (NHL) is a monoclonal neoplastic proliferation of lymphoid cells that can arise in different components of the immune system. Methotrexate (MTX), an antifolate agent, is widely used in the treatment of malignancies and…
View article: Demographic Patterns and Clinical Features of Burkitt Lymphoma Among Patients Visiting Moi Teaching and Referral Hospital, Kenya
Demographic Patterns and Clinical Features of Burkitt Lymphoma Among Patients Visiting Moi Teaching and Referral Hospital, Kenya Open
Background: Kenya is among the high-risk geographical zones especially for the African- endemic variant of Burkitt Lymphoma (BL). It accounts for up to half of all children cases of non-Hodgkin’s lymphomas in tropical Africa. There is limi…
View article: Cerebral Venous Thrombosis in Pediatric Oncology: A Case of Burkitt Lymphoma
Cerebral Venous Thrombosis in Pediatric Oncology: A Case of Burkitt Lymphoma Open
Cerebral venous thrombosis (CVT) is an uncommon but serious complication in pediatric patients with cancer. We report the case of a nine-year-old boy diagnosed with Burkitt lymphoma involving the nasopharyngeal region, who developed superi…
View article: Simultaneous Maxillofacial, Abdominal, and Bone Marrow Involvement in a Pediatric Patient With Epstein-Barr Virus-Associated Burkitt Lymphoma: A Case From India
Simultaneous Maxillofacial, Abdominal, and Bone Marrow Involvement in a Pediatric Patient With Epstein-Barr Virus-Associated Burkitt Lymphoma: A Case From India Open
Burkitt lymphoma is a rare and aggressive B-cell origin non-Hodgkin lymphoma, which has been classified as a poorly differentiated lymphocytic lymphoma. Three major subtypes of Burkitt lymphoma have been identified, namely endemic, sporadi…
View article: Outcomes of patients with HIV-associated Burkitt lymphoma treated with R-DA-EPOCH regimen: A single-center experience in Shanghai, China
Outcomes of patients with HIV-associated Burkitt lymphoma treated with R-DA-EPOCH regimen: A single-center experience in Shanghai, China Open
View article: Inhibiting the RNA helicase DDX3X in Burkitt lymphoma induces oxydative stress and impedes tumor progression in xenografts
Inhibiting the RNA helicase DDX3X in Burkitt lymphoma induces oxydative stress and impedes tumor progression in xenografts Open
Introduction Burkitt Lymphoma (BL), an aggressive B-cell lymphoma driven by MYC translocations, requires intensive chemotherapy treatments which deliver high effectiveness yet increase future risks of developing secondary malignancies. We …
View article: Novel devimistat results in complete remissions in heavily pretreated Burkitt lymphoma in a phase 2 trial
Novel devimistat results in complete remissions in heavily pretreated Burkitt lymphoma in a phase 2 trial Open
Patients with primary refractory or relapsed (R/R) MYC-driven aggressive B-cell lymphomas, such as Burkitt lymphoma (BL), plasmablastic lymphoma (PBL), and double-hit lymphoma (DHL)/triple-hit lymphoma (THL), have a dismal prognosis with f…
View article: Clinical Validation of Liquid Biopsy for Faster Molecular Diagnosis of EBV-Positive Burkitt Lymphoma
Clinical Validation of Liquid Biopsy for Faster Molecular Diagnosis of EBV-Positive Burkitt Lymphoma Open
Burkitt Lymphoma (BL) is common in sub-Saharan Africa, but its diagnosis is often delayed. Here, we comprehensively evaluate blood-based liquid biopsies from 377 children and young adults with clinically suspected lymphoma for diagnostic a…
View article: Efficacy and safety of rituximab-based chemoimmunotherapy in adult patients with Burkitt lymphoma in Korea
Efficacy and safety of rituximab-based chemoimmunotherapy in adult patients with Burkitt lymphoma in Korea Open
Background Burkitt lymphoma (BL), a rare, aggressive MYC -driven B-cell non-Hodgkin lymphoma (NHL), has endemic, sporadic, and immunodeficiency-associated variants. In Asia, BL accounts for 1–2% of lymphomas, with limited data available on…
View article: Complicated appendicitis as a rare presentation of Burkitt’s lymphoma: a case report
Complicated appendicitis as a rare presentation of Burkitt’s lymphoma: a case report Open
Burkitt lymphoma (BL) is an aggressive B-cell non-Hodgkin lymphoma that rarely involves the appendix and may mimic acute appendicitis, complicating preoperative diagnosis. In the context of nonoperative management for appendicitis, such ma…
View article: Supplementary Figures from DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features
Supplementary Figures from DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features Open
Supplemental Figure 1. Association between genetic alterations and methylation patterns Supplemental Figure 2. Epitypes characteristics and their relation to other lymphomas. Supplemental Figure 3. Comparison of epitype characteristics in …
View article: Data from DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features
Data from DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features Open
The genetic subtypes of Burkitt lymphoma have been defined, but the role of epigenetics remains to be comprehensively characterized. We searched genomic DNA from 218 patients across four continents for recurrent DNA methylation patterns an…
View article: Aggressive Myeloid Sarcoma Mimicking Burkitt's Lymphoma
Aggressive Myeloid Sarcoma Mimicking Burkitt's Lymphoma Open
View article: Case Report: A rare pediatric case of B-cell lymphoblastic lymphoma presenting as an isolated renal mass with EWSR1::FLI1 translocation and germline CHEK2 variant
Case Report: A rare pediatric case of B-cell lymphoblastic lymphoma presenting as an isolated renal mass with EWSR1::FLI1 translocation and germline CHEK2 variant Open
We describe a 5-year-old boy who initially presented with a large left renal mass, suspected to be Wilms tumor (WT). However, biopsy results revealed B-cell lymphoblastic lymphoma (B-LBL) manifesting as an isolated renal mass. Tumor transc…
View article: NFKB1 Mutation and Burkitt Lymphoma: At the Crossroads Between Immunodeficiency and Oncogenesis
NFKB1 Mutation and Burkitt Lymphoma: At the Crossroads Between Immunodeficiency and Oncogenesis Open
Introduction Common variable immunodeficiency (CVID) is a primary immunodeficiency disorder characterized by reduced levels of immunoglobulins and impaired antibody responses, leading to recurrent infections, autoimmunity, and an increased…
View article: 442 | NOVEL DEVIMISTAT RESULTS IN COMPLETE REMISSIONS IN HEAVILY PRE‐TREATED BURKITT LYMPHOMA
442 | NOVEL DEVIMISTAT RESULTS IN COMPLETE REMISSIONS IN HEAVILY PRE‐TREATED BURKITT LYMPHOMA Open